Send me a link:

*Text messaging rates may apply.

 Dow Up 0.04% Nasdaq Down 0.08%

ACADIA Pharmaceuticals Inc. (ACAD)

-NasdaqGS
20.51 Down 0.22(1.06%) 10:15AM EDT - Nasdaq Real Time Price
Prev Close:20.73
Open:20.77
Bid:20.41 x 200
Ask:20.47 x 100
1y Target Est:32.67
Beta:2.79
Next Earnings Date:29-Jul-14ACAD Earnings announcement
Day's Range:20.37 - 20.87
52wk Range:15.64 - 32.00
Volume:139,902
Avg Vol (3m):2,319,480
Market Cap:2.03B
P/E (ttm):N/A
EPS (ttm):-0.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACAD

Comparison

Symbol% ChgMkt Cap
ACADDown 1.06%2.03B
AZNDown 0.28%94.23B
LLYUp 0.18%69.04B
PFEUp 0.30%194.42B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,706.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.80
Quarterly EPS Est (Jun-14) :-0.19
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-1.27

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback